Pavmed Series Z Stock Price To Sales

PAVMZ Stock  USD 0.02  0.0001  0.67%   
PAVmed Series Z fundamentals help investors to digest information that contributes to PAVmed Series' financial success or failures. It also enables traders to predict the movement of PAVmed Stock. The fundamental analysis module provides a way to measure PAVmed Series' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PAVmed Series stock.
Last ReportedProjected for Next Year
Price To Sales Ratio 12.15  11.54 
Price To Sales Ratio is likely to drop to 11.54 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

PAVmed Series Z Company Price To Sales Analysis

PAVmed Series' Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Current PAVmed Series Price To Sales

    
  11.54  
Most of PAVmed Series' fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PAVmed Series Z is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

PAVmed Price To Sales Driver Correlations

Understanding the fundamental principles of building solid financial models for PAVmed Series is extremely important. It helps to project a fair market value of PAVmed Stock properly, considering its historical fundamentals such as Price To Sales. Since PAVmed Series' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PAVmed Series' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PAVmed Series' interrelated accounts and indicators.
0.3-0.58-0.660.750.451.00.790.780.7-0.66-0.160.810.610.820.670.820.810.210.780.870.21-0.43
0.3-0.940.51-0.28-0.70.380.470.1-0.260.180.720.790.93-0.23-0.44-0.23-0.26-0.74-0.290.38-0.740.7
-0.58-0.94-0.220.00.45-0.65-0.6-0.310.010.04-0.52-0.92-1.0-0.080.17-0.09-0.040.52-0.03-0.650.52-0.45
-0.660.51-0.22-0.92-0.97-0.6-0.35-0.66-0.860.760.74-0.110.18-0.91-0.96-0.9-0.92-0.77-0.91-0.5-0.770.92
0.75-0.280.0-0.920.860.720.570.880.96-0.91-0.590.340.020.840.950.840.820.580.80.570.58-0.72
0.45-0.70.45-0.970.860.390.20.560.8-0.72-0.8-0.12-0.420.780.930.780.810.80.80.270.8-0.95
1.00.38-0.65-0.60.720.390.790.780.67-0.64-0.130.850.670.770.620.770.750.150.730.90.15-0.35
0.790.47-0.6-0.350.570.20.790.80.57-0.610.250.850.60.480.450.480.52-0.260.380.47-0.26-0.16
0.780.1-0.31-0.660.880.560.780.80.86-0.92-0.210.610.310.640.730.640.620.190.560.570.19-0.39
0.7-0.260.01-0.860.960.80.670.570.86-0.88-0.540.320.010.780.930.780.760.540.740.530.54-0.67
-0.660.180.040.76-0.91-0.72-0.64-0.61-0.92-0.880.41-0.37-0.05-0.67-0.8-0.67-0.65-0.41-0.63-0.46-0.410.54
-0.160.72-0.520.74-0.59-0.8-0.130.25-0.21-0.540.410.350.48-0.48-0.63-0.48-0.49-0.8-0.55-0.25-0.80.74
0.810.79-0.92-0.110.34-0.120.850.850.610.32-0.370.350.920.360.170.360.34-0.360.280.72-0.360.15
0.610.93-1.00.180.02-0.420.670.60.310.01-0.050.480.920.11-0.150.110.07-0.50.060.68-0.50.42
0.82-0.23-0.08-0.910.840.780.770.480.640.78-0.67-0.480.360.110.91.00.970.680.990.680.68-0.78
0.67-0.440.17-0.960.950.930.620.450.730.93-0.8-0.630.17-0.150.90.90.880.710.870.460.71-0.85
0.82-0.23-0.09-0.90.840.780.770.480.640.78-0.67-0.480.360.111.00.90.970.680.990.680.68-0.78
0.81-0.26-0.04-0.920.820.810.750.520.620.76-0.65-0.490.340.070.970.880.970.60.970.60.6-0.86
0.21-0.740.52-0.770.580.80.15-0.260.190.54-0.41-0.8-0.36-0.50.680.710.680.60.730.271.0-0.75
0.78-0.29-0.03-0.910.80.80.730.380.560.74-0.63-0.550.280.060.990.870.990.970.730.680.73-0.82
0.870.38-0.65-0.50.570.270.90.470.570.53-0.46-0.250.720.680.680.460.680.60.270.680.27-0.22
0.21-0.740.52-0.770.580.80.15-0.260.190.54-0.41-0.8-0.36-0.50.680.710.680.61.00.730.27-0.75
-0.430.7-0.450.92-0.72-0.95-0.35-0.16-0.39-0.670.540.740.150.42-0.78-0.85-0.78-0.86-0.75-0.82-0.22-0.75
Click cells to compare fundamentals

PAVmed Price To Sales Historical Pattern

Today, most investors in PAVmed Series Stock are looking for potential investment opportunities by analyzing not only static indicators but also various PAVmed Series' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's price to sales growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of PAVmed Series price to sales as a starting point in their analysis.
   PAVmed Series Price To Sales   
       Timeline  
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Competition

PAVmed Price To Sales Ratio

Price To Sales Ratio

11.54

At this time, PAVmed Series' Price To Sales Ratio is fairly stable compared to the past year.

PAVmed Price To Sales Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PAVmed Series' direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PAVmed Series could also be used in its relative valuation, which is a method of valuing PAVmed Series by comparing valuation metrics of similar companies.
PAVmed Series is currently under evaluation in price to sales category among its peers.

PAVmed Series Current Valuation Drivers

We derive many important indicators used in calculating different scores of PAVmed Series from analyzing PAVmed Series' financial statements. These drivers represent accounts that assess PAVmed Series' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of PAVmed Series' important valuation drivers and their relationship over time.
201920202021202220232024 (projected)
Market Cap30.8M21.4M100.6M42.8M29.8M57.7M
Enterprise Value31.3M21.1M98.3M39.6M58.9M62.0M

PAVmed Fundamentals

About PAVmed Series Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze PAVmed Series Z's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PAVmed Series using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PAVmed Series Z based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for PAVmed Stock Analysis

When running PAVmed Series' price analysis, check to measure PAVmed Series' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PAVmed Series is operating at the current time. Most of PAVmed Series' value examination focuses on studying past and present price action to predict the probability of PAVmed Series' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PAVmed Series' price. Additionally, you may evaluate how the addition of PAVmed Series to your portfolios can decrease your overall portfolio volatility.